Skip to search boxSkip to navigationSkip to main content

Nerve growth factor promotes CNS cholinergic axonal regeneration into acellular peripheral nerve grafts

  • Theo Hagg(corresponding author)
    ,
  • Adarsh K. Gulati
    ,
  • M. Ali Behzadian
    ,
  • H. Lee Vahlsing
    ,
  • Silvio Varon
    ,
  • Marston Manthorpe
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Peripheral nerve grafts promote vigorous regeneration of adult mammalian CNS axons. Elimination of nerve-associated cells by freeze-thawing abolishes this promoting quality, possibly by creating inhibitory cellular debris and/or destroying the production of stimulatory factors by living Schwann or other cells. Here, debris-free acellular peripheral nerve segments placed between the disconnected septum and the hippocampal formation acquired almost no cholinergic axons after 1 month. However, such acellular nerve grafts treated before implantation with purified β-nerve growth factor (NGF) contained nearly as many longitudinally oriented cholinergic axons as did fresh cellular nerve grafts. These results suggest that (i) NGF is required for the regeneration of adult CNS cholinergic axons into nerve grafts and (ii) an important function of living cells within peripheral nerve may be the production of neuronotrophic factors such as NGF.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 79-88 (10 pages)

Journal (Volume, Issue Number)

Experimental Neurology (Volume 112, Issue 1)

Publication milestones

  • Published - 04/1991

Publication status

Published - 04/1991

ISSN

0014-4886

Publication IDs

  • Scopus: 0025821908
  • PubMed: 2013309

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.17
Fractional count
5
Fractional count
0.83
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
55
Captures
13

Funding Details

We thank C. Murdock, L. Thomas, nical assistance and Dr. P. Salvaterra Hope, Duarte, CA) for the monoclonal research was supported by Grants NS-24834, NSF BNS-88-08285, and and E. Hewitt for skillful tech-(Beckman Institute, City of antibody to ChAT (lE6). This NINCDS NS-25011, NS-16349, BNS 86-17034.
FundersFunding numbers
NSF
BNS-88-08285
NINDS
R01NS025011
Beckman Institute for Advanced Science and Technology, University of Illinois, Urbana-Champaign
lE6